Sapropterin Dihydrochloride

CAS 69056-38-8 7 current records 1 historicalSmall Molecule

Who holds supplier records for Sapropterin Dihydrochloride? 7 organisations hold a current record for Sapropterin Dihydrochloride: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4) and Switzerland (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Sapropterin Dihydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/sapropterin-dihydrochloride

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sapropterin Dihydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India4Switzerland1Country not recorded for 2
Need Sapropterin Dihydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Sapropterin Dihydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • SHIRATORI PHARMCEUTICAL CO LTD
    Inactive DMF 17569 · filed Jul 2004

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sapropterin Dihydrochloride is a synthetic form of tetrahydrobiopterin (BH4), a cofactor necessary for phenylalanine hydroxylase and the hydroxylases involved in the production of neurotransmitters such as dopamine and serotonin. It is used in the treatment of hyperphenylalaninemia in patients with phenylketonuria (PKU).

Chemical identity

IUPAC name
(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one;dihydrochloride
Canonical SMILES
C[C@@H]([C@@H]([C@H]1CNC2=C(N1)C(=O)NC(=N2)N)O)O.Cl.Cl
InChIKey
RKSUYBCOVNCALL-NTVURLEBSA-N
Synonyms
Kuvan API, biopten, dapropterin hydrochloride, kuvan, phenoptin, sun-0588, sapropterin hydrochloride, t-1401, t1401

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Phenylalanine Hydroxylase Activator
Mechanism of action
Breast Cancer Resistance Protein Inhibitors; P-Glycoprotein Inhibitors; Phenylalanine Hydroxylase Activators

Therapeutic areas

Metabolic Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sapropterin Dihydrochloride?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Sapropterin Dihydrochloride: DIPHARMA SA (Switzerland), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHONGQING MIDECO PHARMACEUTICAL CO LTD, HONOUR LAB LTD (India), INNOPHARMAX INC, MAITHRI DRUGS PRIVATE LTD (India) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sapropterin Dihydrochloride Drug Master Files are active?

DIPHARMA SA (DMF 26682, 34926), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 36147), CHONGQING MIDECO PHARMACEUTICAL CO LTD (DMF 42146), HONOUR LAB LTD (DMF 33928), INNOPHARMAX INC (DMF 33553), MAITHRI DRUGS PRIVATE LTD (DMF 41077) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 34185). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sapropterin Dihydrochloride records mean?

1 organisation has only inactive Type II DMFs for Sapropterin Dihydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Sapropterin Dihydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sapropterin Dihydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.